The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Polyneuropathies

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Polyneuropathies

 

Psychiatry related information on Polyneuropathies

 

High impact information on Polyneuropathies

 

Chemical compound and disease context of Polyneuropathies

 

Biological context of Polyneuropathies

 

Anatomical context of Polyneuropathies

 

Gene context of Polyneuropathies

 

Analytical, diagnostic and therapeutic context of Polyneuropathies

References

  1. Identification of PAHX, a Refsum disease gene. Mihalik, S.J., Morrell, J.C., Kim, D., Sacksteder, K.A., Watkins, P.A., Gould, S.J. Nat. Genet. (1997) [Pubmed]
  2. Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. Schaumburg, H.H., Berger, A. JAMA (1992) [Pubmed]
  3. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome. Hogan-Dann, C.M., Fellmeth, W.G., McGuire, S.A., Kiley, V.A. JAMA (1984) [Pubmed]
  4. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. Salomon, B., Rhee, L., Bour-Jordan, H., Hsin, H., Montag, A., Soliven, B., Arcella, J., Girvin, A.M., Padilla, J., Miller, S.D., Bluestone, J.A. J. Exp. Med. (2001) [Pubmed]
  5. Controlled trial prednisolone in acute polyneuropathy. Hughes, R.A., Newsom-Davis, J.M., Perkin, G.D., Pierce, J.M. Lancet (1978) [Pubmed]
  6. Restless legs syndrome. A review. O'Keeffe, S.T. Arch. Intern. Med. (1996) [Pubmed]
  7. Recurrent attacks of unconsciousness with diffuse EEG alpha activity. Lotz, B.P., Schutte, C.M., Bartel, P.R., Jacobs, E. Sleep. (1993) [Pubmed]
  8. Alcohol and the central nervous system. Nakada, T., Knight, R.T. Med. Clin. North Am. (1984) [Pubmed]
  9. Clomipramine and imipramine suppress clinical signs and T and B cell response to myelin proteins in experimental autoimmune neuritis in Lewis rats. Zhu, J., Bengtsson, B.O., Mix, E., Ekerling, L., Thorell, L.H., Olsson, T., Link, H. J. Autoimmun. (1998) [Pubmed]
  10. Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP). Sales-Luís, M.d.e. .L., Conceição, I., de Carvalho, M. Amyloid (2003) [Pubmed]
  11. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. Partanen, J., Niskanen, L., Lehtinen, J., Mervaala, E., Siitonen, O., Uusitupa, M. N. Engl. J. Med. (1995) [Pubmed]
  12. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. Sima, A.A., Bril, V., Nathaniel, V., McEwen, T.A., Brown, M.B., Lattimer, S.A., Greene, D.A. N. Engl. J. Med. (1988) [Pubmed]
  13. A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. Pras, M., Franklin, E.C., Prelli, F., Frangione, B. J. Exp. Med. (1981) [Pubmed]
  14. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. Saraiva, M.J., Costa, P.P., Goodman, D.S. J. Clin. Invest. (1985) [Pubmed]
  15. Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide. Fowler, H., Vulpe, M., Marks, G., Egolf, C., Dau, P.C. Lancet (1979) [Pubmed]
  16. Acute polyneuropathy possibly associated with co-trimoxazole. Vincent, F.M. Lancet (1977) [Pubmed]
  17. Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy. Jones, L.A., Skare, J.C., Harding, J.A., Cohen, A.S., Milunsky, A., Skinner, M. Am. J. Hum. Genet. (1991) [Pubmed]
  18. Diagnosis of Maryland/German familial amyloidotic polyneuropathy using allele-specific, enzymatically amplified, genomic DNA. Mendell, J.R., Jiang, X.S., Warmolts, J.R., Nichols, W.C., Benson, M.D. Ann. Neurol. (1990) [Pubmed]
  19. Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies. Meijerink, P.H., Hoogendijk, J.E., Gabreëls-Festen, A.A., Zorn, I., Veldman, H., Baas, F., de Visser, M., Bolhuis, P.A. Ann. Neurol. (1996) [Pubmed]
  20. Late-onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: compound heterozygosity for the IVS2+1G-->A mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family. Comabella, M., Waye, J.S., Raguer, N., Eng, B., Domínguez, C., Navarro, C., Borrás, C., Krivit, W., Montalbán, X. Ann. Neurol. (2001) [Pubmed]
  21. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Kohno, K., Palha, J.A., Miyakawa, K., Saraiva, M.J., Ito, S., Mabuchi, T., Blaner, W.S., Iijima, H., Tsukahara, S., Episkopou, V., Gottesman, M.E., Shimada, K., Takahashi, K., Yamamura, K., Maeda, S. Am. J. Pathol. (1997) [Pubmed]
  22. Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy. Crosby, S.R., Tsigos, C., Anderton, C.D., Gordon, C., Young, R.J., White, A. Diabetologia (1992) [Pubmed]
  23. A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Jenne, D.E., Denzel, K., Blätzinger, P., Winter, P., Obermaier, B., Linke, R.P., Altland, K. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  24. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Dalakas, M.C., Engel, W.K. Ann. Neurol. (1981) [Pubmed]
  25. Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesions. Hanyu, N., Ikeda, S., Nakadai, A., Yanagisawa, N., Powell, H.C. Ann. Neurol. (1989) [Pubmed]
  26. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Gabriel, J.M., Erne, B., Miescher, G.C., Miller, S.L., Vital, A., Vital, C., Steck, A.J. Brain (1996) [Pubmed]
  27. Synthesis of an analog of the thyroid hormone-binding protein transthyretin via regioselective chemical ligation. Wilce, J.A., Love, S.G., Richardson, S.J., Alewood, P.F., Craik, D.J. J. Biol. Chem. (2001) [Pubmed]
  28. Inherited neuropathies: from gene to disease. Keller, M.P., Chance, P.F. Brain Pathol. (1999) [Pubmed]
  29. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Murata, K., Dalakas, M.C. Brain (2000) [Pubmed]
  30. Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis. Grundström, E., Askmark, H., Lindeberg, J., Nygren, I., Ebendal, T., Aquilonius, S.M. J. Neurol. Sci. (1999) [Pubmed]
  31. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Scarlato, M., Previtali, S.C., Carpo, M., Pareyson, D., Briani, C., Del Bo, R., Nobile-Orazio, E., Quattrini, A., Comi, G.P. Brain (2005) [Pubmed]
  32. Immunofluorescence study of patients with neuropathy and IgM M proteins. Takatsu, M., Hays, A.P., Latov, N., Abrams, G.M., Nemni, R., Sherman, W.H., Nobile-Orazio, E., Saito, T., Freddo, L. Ann. Neurol. (1985) [Pubmed]
  33. The treatment of advanced metastatic seminoma: experience in 55 cases. Fosså, S.D., Borge, L., Aass, N., Johannessen, N.B., Stenwig, A.E., Kaalhus, O. J. Clin. Oncol. (1987) [Pubmed]
  34. Cells secreting anti-MAG antibody occur in cerebrospinal fluid and bone marrow in patients with polyneuropathy associated with M component. Baig, S., Jiang, Y.P., Olsson, T., Cruz, M., Link, H. Brain (1991) [Pubmed]
  35. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. el-Salhy, M., Suhr, O., Stenling, R., Wilander, E., Grimelius, L. Gut (1994) [Pubmed]
 
WikiGenes - Universities